TABLE 4.
Outcome and variable | No. of patients | OR (95% CI) | P value |
---|---|---|---|
Clinical response | |||
ICU stay during infection | 0.0054 | ||
No | 37 | 3.7 (1.5, 9.2) | |
Yes | 58 | 1.0 | |
Treatment | 0.026 | ||
Colistin | 31 | 2.9 (1.1, 7.6) | |
Control | 64 | 1.0 | |
Microbial response | |||
ICU stay during infection | 0.0053 | ||
No | 37 | 3.5 (1.5, 8.4) | |
Yes | 58 | 1.0 | |
Treatment | 0.24 | ||
Colistin | 31 | 1.7 (0.7, 4.3) | |
Control | 64 | 1.0 | |
Infection-related death | |||
Underlying disease | 0.019 | ||
Leukemia | 44 | 5.0 (1.3, 19.4) | |
Lymphoma/myeloma | 13 | 11.3 (1.7, 72.7) | |
Solid tumor | 38 | 1.0 | |
ICU stay during infection | 0.0018 | ||
Yes | 58 | 14.2 (2.7, 74.7) | |
No | 37 | 1.0 | |
Treatment | 0.92 | ||
Colistin | 31 | 1.1 (0.3, 3.5) | |
Control | 64 | 1.0 |